REBOA（蘇生的大動脈内バルーン遮断）の市場規模、シェア、動向分析レポート：用途別、地域別、セグメント別予測、2024年～2030年

市場規模と動向：

REBOA（蘇生的大動脈内バルーン遮断）の世界市場規模は、2023年に958万米ドルと評価され、2024年から2030年にかけてCAGR 19.9％で成長すると予測されています。

この市場を牽引しているのは、臨床現場での成長と採用に影響を与えるいくつかの重要な要因です。これらの促進要因には、外傷性損傷の有病率の増加、医療技術の進歩、外傷治療プロトコルの重視の高まり、ヘルスケア専門家の意識の高まり、政府の支援的イニシアチブなどがあります。これらの各要素は、市場展望を形成し、救命介入としてのREBOAの利用を強化する上で重要な役割を果たしています。

外傷、特に交通事故、転倒、暴力による外傷の発生率の上昇は、REBOA（蘇生的大動脈内バルーン遮断）市場の重要な促進要因です。外傷症例はしばしば出血性ショックにつながるため、効果的な蘇生技術の需要が急増しています。REBOAは、緊急事態に迅速に展開できる低侵襲な選択肢を提供し、外傷外科医や救急医療サービスにとって魅力的な選択肢となっています。2024年6月、世界保健機関（WHO）は、意図的でない外傷と暴力による外傷の両方が外傷に大きく寄与しており、年間440万人が死亡していると報告しました。特に小児期にトラウマにさらされると、精神衛生上の問題、薬物乱用、慢性疾患、社会的問題のリスクが高まる。

医療機器の技術的進歩は、REBOAの有効性と安全性を著しく高めています。改良されたバルーンのデザイン、より優れたカテーテルシステム、画像技術の向上といった技術革新は、手技中のより正確な配置とモニタリングを容易にしています。これらの進歩は、患者の予後を改善するだけでなく、ヘルスケアプロバイダーがREBOAを外傷治療の標準的な手法として採用することを後押ししています。2024年6月、ユタ州を拠点とするエマージェンシー・サイエンティフィック社は、FDA510（k）認可後、同社のLandmark REBOAカテーテルを初めて使用することを発表しました。このカテーテルは、緊急出血管理における太い血管の一時的な閉塞用です。Landmarkカテーテルは、従来の方法に伴う合併症を最小限に抑えつつ、閉塞の精度を高めるよう設計されています。

外傷性出血の管理におけるREBOAの利点について、ヘルスケア専門家の間で認識が高まっています。このような認識とともに、REBOAの適切な使用法について臨床医を教育するための専門的なトレーニングプログラムが開発されつつあります。このように教育が重視されるようになったことで、より多くのヘルスケアプロバイダーが、この救命処置を効果的に実施するために必要な知識とスキルを身につけることができるようになった。2024年3月、Journal of Emergency Medicine誌に、救急医研修医のためにデザインされた新しいREBOAトレーニングカリキュラムに関するパイロットスタディ（A Pilot Study on A Novel REBOA Training Curriculum designed for Emergency Medicine）の詳細が掲載されました。この最先端のカリキュラムは、REBOA手技を適用する際の救急科研修医の能力と理解を向上させ、生命を脅かすシナリオにおける患者の転帰を改善することを目的として設計されました。

医療機器を取り巻く規制環境は、REBOAのような革新的なソリューションをますます支持するようになっています。規制機関は外傷治療における迅速な介入技術の重要性を認識しており、新しい機器の承認プロセスを合理化しています。このような支援姿勢は、メーカーが研究開発に投資することを促し、市場成長をさらに促進します。2024年2月、Neurescue社はシリーズA資金調達ラウンドで727万米ドルを調達したと発表しました。この投資はロンドンを拠点とする投資会社West Hill Capitalが主導しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 REBOA（蘇生的大動脈内バルーン遮断）市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場牽引要因分析
  • 市場抑制要因分析
• REBOA（蘇生的大動脈内バルーン遮断）市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 REBOA（蘇生的大動脈内バルーン遮断）市場： 最終用途の推定・動向分析

• 世界のREBOA（蘇生的大動脈内バルーン遮断）市場：最終用途ダッシュボード
• 世界のREBOA（蘇生的大動脈内バルーン遮断）市場：最終用途変動分析
• 最終用途別収益
• 心停止
• 大動脈閉塞症
• 戦術的戦闘負傷者ケア

第5章 REBOA（蘇生的大動脈内バルーン遮断）市場： 用途、タイプ、最終用途別の地域推定・動向分析

• 地域ダッシュボード
• 市場規模、予測動向分析、2018年から2030年：
• 北米
• 欧州
• アジア太平洋

第6章 競合情勢

• 企業/競合の分類
• ベンダー情勢
  • 主要販売代理店およびチャネルパートナーのリスト
  • 主要顧客
  • 主要企業の市場シェア分析、2023年
  • Prytime Medical Devices, Inc
  • NEURESCUE
  • Emergency Scientific, LLC
  • Qx Medical
  • Front Line Medical Technologies
  • Reboa Medical As

List of Tables

• Table 1 List of abbreviation
• Table 2 North America resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by region, 2018 - 2030 (USD Million)
• Table 3 North America resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
• Table 4 U.S. resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
• Table 5 Canada resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
• Table 6 Europe resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by region, 2018 - 2030 (USD Million)
• Table 7 Europe resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
• Table 8 Germany resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
• Table 9 UK resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
• Table 10 France resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
• Table 11 Italy resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
• Table 12 Spain resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
• Table 13 Asia Pacific resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by region, 2018 - 2030 (USD Million)
• Table 14 Aisa Pacific resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
• Table 15 China resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)
• Table 16 Japan resuscitative endovascular balloon occlusion of the aorta (REBOA) market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Market research process
• Fig. 2 Data triangulation techniques
• Fig. 3 Primary research pattern
• Fig. 4 Market research approaches
• Fig. 5 Value-chain-based sizing & forecasting
• Fig. 6 QFD modeling for market share assessment
• Fig. 7 Market formulation & validation
• Fig. 8 Resuscitative endovascular balloon occlusion of the aorta (REBOA) market: market outlook
• Fig. 9 Resuscitative endovascular balloon occlusion of the aorta (REBOA) competitive insights
• Fig. 10 Parent market outlook
• Fig. 11 Related/ancillary market outlook
• Fig. 12 Resuscitative endovascular balloon occlusion of the aorta (REBOA) market driver impact
• Fig. 13 Resuscitative endovascular balloon occlusion of the aorta (REBOA) market restraint impact
• Fig. 14 Resuscitative endovascular balloon occlusion of the aorta (REBOA) market: End use movement analysis
• Fig. 15 Resuscitative endovascular balloon occlusion of the aorta (REBOA) market: End use outlook and key takeaways
• Fig. 16 Cardiac arrest market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 17 Aortic occlusion market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 18 Tactical combat casualty care market estimates and forecast, 2018 - 2030 (USD Million)
• Fig. 19 Global resuscitative endovascular balloon occlusion of the aorta (REBOA) market: Regional movement analysis
• Fig. 20 Global resuscitative endovascular balloon occlusion of the aorta (REBOA) market: Regional outlook and key takeaways
• Fig. 21 Global resuscitative endovascular balloon occlusion of the aorta (REBOA) market share and leading players
• Fig. 22 North America, by country
• Fig. 23 North America market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 24 U.S. key country dynamics
• Fig. 25 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 26 Canada key country dynamics
• Fig. 27 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 28 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 29 UK key country dynamics
• Fig. 30 UK market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 31 Germany key country dynamics
• Fig. 32 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 France key country dynamics
• Fig. 34 France market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Italy key country dynamics
• Fig. 36 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 37 Spain key country dynamics
• Fig. 38 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 China key country dynamics
• Fig. 41 China market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Japan key country dynamics
• Fig. 43 Japan market estimates and forecasts, 2018 - 2030 (USD Million)

Market Size & Trends:

The global resuscitative endovascular balloon occlusion of the aorta market size was valued at USD 9.58 million in 2023 and is projected to grow at a CAGR of 19.9% from 2024 to 2030. The market is driven by several key factors that influence its growth and adoption in clinical settings. These drivers include the increasing prevalence of traumatic injuries, advancements in medical technology, a growing emphasis on trauma care protocols, rising awareness among healthcare professionals, and supportive government initiatives. Each of these elements plays a crucial role in shaping the market landscape and enhancing the utilization of REBOA as a life-saving intervention.

The rising incidence of traumatic injuries, particularly those resulting from road accidents, falls, and violence, is a significant driver for the Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) market. As trauma cases often lead to hemorrhagic shock, the demand for effective resuscitation techniques has surged. REBOA provides a minimally invasive option that can be rapidly deployed in emergency situations, making it an attractive choice for trauma surgeons and emergency medical services. In June 2024, the World Health Organization reported that injuries, both unintentional and violence-related, significantly contribute to trauma, leading to 4.4 million deaths annually. Exposure to trauma, especially during childhood, can heighten the risk of mental health issues, substance abuse, chronic diseases, and social problems.

Technological advancements in medical devices have significantly enhanced the efficacy and safety of REBOA procedures. Innovations such as improved balloon designs, better catheter systems, and enhanced imaging technologies facilitate more precise placement and monitoring during procedures. These advancements not only improve patient outcomes but also encourage healthcare providers to adopt REBOA as a standard practice in trauma care. In June 2024, Emergency Scientific, a Utah-based firm, announced the first use of its Landmark REBOA catheter, following its FDA 510(k) clearance. This device is for temporary occlusion of large vessels in emergency hemorrhage control. The Landmark catheter is designed to enhance the precision of occlusion while minimizing complications associated with traditional methods.

There is an increasing awareness among healthcare professionals regarding the benefits of REBOA in managing traumatic hemorrhage. Alongside this awareness, specialized training programs are being developed to educate clinicians on the proper use of REBOA techniques. This growing emphasis on education ensures that more healthcare providers are equipped with the knowledge and skills necessary to implement this life-saving procedure effectively. In March 2024, an article was published in the Journal of Emergency Medicine detailing A Pilot Study on A Novel REBOA Training Curriculum designed for Emergency Medicine Residents. This cutting-edge curriculum was designed to advance the competencies and understanding of Emergency Medicine residents in applying the REBOA technique, with the aim of bettering patient outcomes in life-threatening scenarios.

The regulatory environment surrounding medical devices has become increasingly supportive of innovative solutions like REBOA. Regulatory bodies are recognizing the importance of rapid intervention techniques in trauma care and are streamlining approval processes for new devices. This supportive stance encourages manufacturers to invest in research and development, further propelling market growth. In February 2024, Neurescue announced that it raised USD 7.27 million in a Series A funding round. This investment was spearheaded by West Hill Capital, a London-based investment firm.

Global Resuscitative Endovascular Balloon Occlusion Of The Aorta Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global resuscitative endovascular balloon occlusion of the aorta market report based on end-use, and region:

• End-use Outlook (Revenue, USD Million, 2018 - 2030)
• Cardiac Arrest
• Aortic Occlusion
• Tactical Combat Casualty Care
• Regional Outlook (Revenue, USD Million, 2018 - 2030)
• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
• Asia Pacific
  • China
  • Japan

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. End Use
  • 1.2.2. Regional scope
  • 1.2.3. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. End Use outlook
  • 2.2.2. Regional outlook
• 2.3. Competitive Insights

Chapter 3. Resuscitative Endovascular Balloon Occlusion of The Aorta (REBOA) Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing incidence of trauma cases
    • 3.2.1.2. Technological advancements
    • 3.2.1.3. Growing awareness and training programs
    • 3.2.1.4. Military applications
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Cost considerations
    • 3.2.2.2. Regulatory challenges
• 3.3. Resuscitative Endovascular Balloon Occlusion of The Aorta (REBOA) Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Supplier power
    • 3.3.1.2. Buyer power
    • 3.3.1.3. Substitution threat
    • 3.3.1.4. Threat of new entrant
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Technological landscape
    • 3.3.2.3. Economic landscape

Chapter 4. Resuscitative Endovascular Balloon Occlusion of The Aorta (REBOA) Market: End Use Estimates & Trend Analysis

• 4.1. Global Resuscitative Endovascular Balloon Occlusion of The Aorta (REBOA) Market: End Use Dashboard
• 4.2. Global Resuscitative Endovascular Balloon Occlusion of The Aorta (REBOA) Market: End Use Movement Analysis
• 4.3. Global Resuscitative Endovascular Balloon Occlusion of The Aorta (REBOA) Market Estimates and Forecasts, by End Use, Revenue (USD Million)
• 4.4. Cardiac Arrest
  • 4.4.1. Cardiac arrest market estimates and forecasts 2018 to 2030 (USD Million)
• 4.5. Aortic Occlusion
  • 4.5.1. Aortic occlusion market estimates and forecasts 2018 to 2030 (USD Million)
• 4.6. Tactical Combat Casualty Care
  • 4.6.1. Tactical combat casualty care market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Resuscitative Endovascular Balloon Occlusion of The Aorta (REBOA) Market: Regional Estimates & Trend Analysis by Application, Type, and End Use

• 5.1. Regional Dashboard
• 5.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 5.3. North America
  • 5.3.1. U.S.
    • 5.3.1.1. Key country dynamics
    • 5.3.1.2. Regulatory framework/ reimbursement structure
    • 5.3.1.3. Competitive scenario
    • 5.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.3.2. Canada
    • 5.3.2.1. Key country dynamics
    • 5.3.2.2. Regulatory framework/ reimbursement structure
    • 5.3.2.3. Competitive scenario
    • 5.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 5.4. Europe
  • 5.4.1. UK
    • 5.4.1.1. Key country dynamics
    • 5.4.1.2. Regulatory framework/ reimbursement structure
    • 5.4.1.3. Competitive scenario
    • 5.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.2. Germany
    • 5.4.2.1. Key country dynamics
    • 5.4.2.2. Regulatory framework/ reimbursement structure
    • 5.4.2.3. Competitive scenario
    • 5.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.3. France
    • 5.4.3.1. Key country dynamics
    • 5.4.3.2. Regulatory framework/ reimbursement structure
    • 5.4.3.3. Competitive scenario
    • 5.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.4. Italy
    • 5.4.4.1. Key country dynamics
    • 5.4.4.2. Regulatory framework/ reimbursement structure
    • 5.4.4.3. Competitive scenario
    • 5.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.4.5. Spain
    • 5.4.5.1. Key country dynamics
    • 5.4.5.2. Regulatory framework/ reimbursement structure
    • 5.4.5.3. Competitive scenario
    • 5.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
• 5.5. Asia Pacific
  • 5.5.1. Japan
    • 5.5.1.1. Key country dynamics
    • 5.5.1.2. Regulatory framework/ reimbursement structure
    • 5.5.1.3. Competitive scenario
    • 5.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 5.5.2. China
    • 5.5.2.1. Key country dynamics
    • 5.5.2.2. Regulatory framework/ reimbursement structure
    • 5.5.2.3. Competitive scenario
    • 5.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Competitive Landscape

• 6.1. Company/Competition Categorization
• 6.2. Vendor Landscape
  • 6.2.1. List of key distributors and channel partners
  • 6.2.2. Key customers
  • 6.2.3. Key company market share analysis, 2023
  • 6.2.4. Prytime Medical Devices, Inc
    • 6.2.4.1. Company overview
    • 6.2.4.2. Financial performance
    • 6.2.4.3. Product benchmarking
    • 6.2.4.4. Strategic initiatives
  • 6.2.5. NEURESCUE
    • 6.2.5.1. Company overview
    • 6.2.5.2. Financial performance
    • 6.2.5.3. Product benchmarking
    • 6.2.5.4. Strategic initiatives
  • 6.2.6. Emergency Scientific, LLC
    • 6.2.6.1. Company overview
    • 6.2.6.2. Financial performance
    • 6.2.6.3. Product benchmarking
    • 6.2.6.4. Strategic initiatives
  • 6.2.7. Qx Medical
    • 6.2.7.1. Company overview
    • 6.2.7.2. Financial performance
    • 6.2.7.3. Product benchmarking
    • 6.2.7.4. Strategic initiatives
  • 6.2.8. Front Line Medical Technologies
    • 6.2.8.1. Company overview
    • 6.2.8.2. Financial performance
    • 6.2.8.3. Product benchmarking
    • 6.2.8.4. Strategic initiatives
  • 6.2.9. Reboa Medical As
    • 6.2.9.1. Company overview
    • 6.2.9.2. Financial performance
    • 6.2.9.3. Product benchmarking
    • 6.2.9.4. Strategic initiatives